Fibulin-3 serum and urine levels in the diagnosis and severity assessment of primary knee osteoarthritis
Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Data nadesłania: 09-08-2019
Data ostatniej rewizji: 12-10-2019
Data akceptacji: 17-10-2019
Data publikacji online: 31-10-2019
Data publikacji: 19-11-2019
Reumatologia 2019;57(5):271-276
Osteoarthritis (OA) is the most widespread joint disease and is a major cause of joint pain and disability in the middle aged and elderly population. The diagnosis of OA is based on clinical and radiographic changes that occur late after disease progression, and hence does not allow early detection of structural damage. Therefore, there is an acute need for reliable biochemical markers that can facilitate its earlier diagnosis. This study was commenced to identify fibulin-3 levels in serum and urine of patients with primary knee OA and to investigate their relationship with severity of the disease.

Material and methods:
Fifty female patients with primary knee OA were compared to 25 healthy female controls. Fibulin-3 in serum and urine were measured using enzyme-linked immunosorbent assay (ELISA). Severity of knee pain was assessed by the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index and the Knee Outcome Survey Activities of Daily Living (KOS-ADL) scale. Radiographic grading of knee OA was performed by Kellgren-Lawrence (K-L) criteria.

Serum and urine fibulin-3 were higher in patients (286.00 ±145.00 ng/ml and 104.60 ±32.73 ng/ml, respectively) than in controls (26.00 ±5.77 ng/ml and 13.60 ±4.21 ng/ml, respectively). Fibulin-3 in serum and urine correlated (p < 0.001) with each other (r = 0.930) and with the severity of knee pain by WOMAC index (r = 0.909 and 0.928, respectively), inversely correlated with KOS-ADL (r = –0.913 and –0.953, respectively), and with radiographic grading of K-L (r = 0.855 and 0.875, respectively).

Fibulin-3 serves as a biomarker of knee OA disease severity and could predict disease progression. Assessing urine fibulin-3 could be an applicable and easy method to diagnose knee OA and to follow up disease progression.

Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers 2016; 2: 16072.
Xu L, Zhu GB, Wang L, et al. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012; 60: 583-586.
Pulsatelli L, Addimanda O, Brusi V, et al. New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis 2013; 4: 23-43.
Runhaar J, Sanchez C, Taralla S, et al. Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis Cartilage 2016; 24: 672-678.
Bay-Jensen AC, Henrotin Y, Karsdal M, et al. The need for predictive, prognostic, objective and complementary blood-based biomarkers in osteoarthritis (OA). EBioMedicine 2016; 7: 4-6.
de Visser HM, Mastbergen SC, Kozijn AE, et al. Metabolic dysregulation accelerates injury-induced joint degeneration, driven by local inflammation; an in vivo rat study. J Orthop Res 2018; 36: 881-890.
Zhang Y, Marmorstein LY. Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res 2010; 90: 374-375.
Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006; 66: 2621-2629.
Henrotin Y, Gharbi M, Mazzucchelli G, et al. Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 2012; 64: 2260-2267.
Henrotin Y, Sanchez C, Bay-Jensen AC, et al. Osteoarthritis biomarkers derived from cartilage extracellular matrix: current status and future perspectives. Ann Phys Rehabil Med 2016; 59: 145-148.
Ehlermann J, Weber S, Pfisterer P, et al. Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne-Honeycomb retinal dystrophy. Gene Expr Patterns 2003; 3: 441-447.
McLaughlin PJ, Bakall B, Choi J, et al. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum Mol Genet 2007; 16: 3059-3070.
Rahn DD, Acevedo JF, Roshanravan S, et al. Failure of pelvic organ support in mice deficient in fibulin-3. Am J Pathol 2009; 174: 206-215.
Segade F. Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. Gene 2010; 464: 17-31.
Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 1986; 29: 1039-1049.
Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation Study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1998; 15: 1833-1840.
Irrgang JJ, Snyder-Mackler L, Wainner RS, et al. Development of a patient-reported measure of function of the knee. J Bone Joint Surg Am 1998; 80: 1132-1145.
Bizzini M, Gorelick M. Development of a German version of the knee outcome survey for daily activities. Arch Orthop Trauma Surg 2007; 127: 781-789.
Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957; 16: 494-502.
Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly. The Framingham osteoarthritis study. Arthritis Rheum 1987; 30: 914-918.
Wu Q, Suna X, Du L. Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study. Knee 2017; 24: 1369-1373.
Wakabayashi T, Matsumine A, Nakazora S, et al. Fibulin-3 negatively regulates chondrocyte differentiation. Biochem Biophys Res Commun 2010; 391: 1116-1121.
Halper J, Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol 2014; 802: 31-47.
Sharma L, Lou C, Felson DT, et al. Laxity in healthy and osteoarthritic knees. Arthritis Rheum 1999; 42: 861-870.
Miura H, Takasugi S, Kawano T, et al. Varus-valgus laxity correlates with pain in osteoarthritis of the knee. Knee 2009; 16: 30-32.
Aunan E, Kibsgård TJ, Diep LM, et al. Intraoperative ligament laxity influences functional outcome 1 year after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2015; 23: 1684-1692.
Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006; 14: 723-727.
Kopeć-Mędrek M, Kucharz EJ. Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with anti-TNF therapy. Adv Clin Exp Med 2018; 27: 383-389.
Blackburn J, Tarttelin EE, Gregory-Evans CY, et al. Transcriptional Regulation and Expression of the Dominant Drusen Gene FBLN3 (EFEMP1) in Mammalian Retina. Invest Ophthalmol Vis Sci 2003; 44: 4613-4621.
Hulleman JD, Brown SJ, Rosen H, et al. A High-Throughput Cell-Based Gaussia Luciferase Reporter Assay for Identifying Modulators of Fibulin-3 Secretion. J Biomol Screen 2013; 18: 647-658.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top